The relevance of transforming growth factor β1 in pulmonary injury after radiation therapy

Mitchell S. Anscher, Feng Ming Kong, Randy L. Jirtle

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

The maximum dose of radiation which can be delivered to a tumor is limited by the tolerance of the surrounding normal tissues. The ability to identify patients at high or low risk of injury from radiation therapy might enable the clinician to tailor radiation doses in order to maximize efficacy and minimize risk. The cytokine transforming growth factor β1 (TGFβ1) has been implicated in the development of normal tissue injury after irradiation in several organs, including the lung. Herein, the evidence supporting the role of TGFβ1 in radiation-induced lung injury is reviewed. Using the treatment of non-small cell lung cancer as a model, we also discuss how it may be possible to identify patients at risk for this complication using measurements of plasma TGFβ1, and how this information may be used in the future to adjust doses of radiation in the treatment of lung cancer.

Original languageEnglish (US)
Pages (from-to)109-120
Number of pages12
JournalLung Cancer
Volume19
Issue number2
DOIs
StatePublished - Feb 1 1998

Fingerprint

Lung Injury
Transforming Growth Factors
Radiotherapy
Radiation
Wounds and Injuries
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Cytokines
Lung
Therapeutics
Neoplasms

Keywords

  • Complications
  • Lung cancer
  • Radiation therapy
  • Transforming growth factor β

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

The relevance of transforming growth factor β1 in pulmonary injury after radiation therapy. / Anscher, Mitchell S.; Kong, Feng Ming; Jirtle, Randy L.

In: Lung Cancer, Vol. 19, No. 2, 01.02.1998, p. 109-120.

Research output: Contribution to journalArticle

Anscher, Mitchell S. ; Kong, Feng Ming ; Jirtle, Randy L. / The relevance of transforming growth factor β1 in pulmonary injury after radiation therapy. In: Lung Cancer. 1998 ; Vol. 19, No. 2. pp. 109-120.
@article{9d215df0f6124827a99f8bd2bad66ab0,
title = "The relevance of transforming growth factor β1 in pulmonary injury after radiation therapy",
abstract = "The maximum dose of radiation which can be delivered to a tumor is limited by the tolerance of the surrounding normal tissues. The ability to identify patients at high or low risk of injury from radiation therapy might enable the clinician to tailor radiation doses in order to maximize efficacy and minimize risk. The cytokine transforming growth factor β1 (TGFβ1) has been implicated in the development of normal tissue injury after irradiation in several organs, including the lung. Herein, the evidence supporting the role of TGFβ1 in radiation-induced lung injury is reviewed. Using the treatment of non-small cell lung cancer as a model, we also discuss how it may be possible to identify patients at risk for this complication using measurements of plasma TGFβ1, and how this information may be used in the future to adjust doses of radiation in the treatment of lung cancer.",
keywords = "Complications, Lung cancer, Radiation therapy, Transforming growth factor β",
author = "Anscher, {Mitchell S.} and Kong, {Feng Ming} and Jirtle, {Randy L.}",
year = "1998",
month = "2",
day = "1",
doi = "10.1016/S0169-5002(97)00076-7",
language = "English (US)",
volume = "19",
pages = "109--120",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - The relevance of transforming growth factor β1 in pulmonary injury after radiation therapy

AU - Anscher, Mitchell S.

AU - Kong, Feng Ming

AU - Jirtle, Randy L.

PY - 1998/2/1

Y1 - 1998/2/1

N2 - The maximum dose of radiation which can be delivered to a tumor is limited by the tolerance of the surrounding normal tissues. The ability to identify patients at high or low risk of injury from radiation therapy might enable the clinician to tailor radiation doses in order to maximize efficacy and minimize risk. The cytokine transforming growth factor β1 (TGFβ1) has been implicated in the development of normal tissue injury after irradiation in several organs, including the lung. Herein, the evidence supporting the role of TGFβ1 in radiation-induced lung injury is reviewed. Using the treatment of non-small cell lung cancer as a model, we also discuss how it may be possible to identify patients at risk for this complication using measurements of plasma TGFβ1, and how this information may be used in the future to adjust doses of radiation in the treatment of lung cancer.

AB - The maximum dose of radiation which can be delivered to a tumor is limited by the tolerance of the surrounding normal tissues. The ability to identify patients at high or low risk of injury from radiation therapy might enable the clinician to tailor radiation doses in order to maximize efficacy and minimize risk. The cytokine transforming growth factor β1 (TGFβ1) has been implicated in the development of normal tissue injury after irradiation in several organs, including the lung. Herein, the evidence supporting the role of TGFβ1 in radiation-induced lung injury is reviewed. Using the treatment of non-small cell lung cancer as a model, we also discuss how it may be possible to identify patients at risk for this complication using measurements of plasma TGFβ1, and how this information may be used in the future to adjust doses of radiation in the treatment of lung cancer.

KW - Complications

KW - Lung cancer

KW - Radiation therapy

KW - Transforming growth factor β

UR - http://www.scopus.com/inward/record.url?scp=0031926223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031926223&partnerID=8YFLogxK

U2 - 10.1016/S0169-5002(97)00076-7

DO - 10.1016/S0169-5002(97)00076-7

M3 - Article

C2 - 9567247

AN - SCOPUS:0031926223

VL - 19

SP - 109

EP - 120

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 2

ER -